Analysis of adverse reactions and risk factors of lapatinib ditosylate in the treatment of breast cancer

doi:10.3969/j.issn.1672-3384.2023.02.009

MA Ying-lin, LIU Min, LE Kai-di, YAN Jia-qing, DONG Bin, WANG Meng-yang, LI Ying, LI Guo-hui

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (2) : 46-50.

PDF(382 KB)

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (2) : 46-50. DOI: 10.3969/j.issn.1672-3384.2023.02.009

Original Article

Analysis of adverse reactions and risk factors of lapatinib ditosylate in the treatment of breast cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(2): 46-50 https://doi.org/10.3969/j.issn.1672-3384.2023.02.009

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(382 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-04-13	2023-02-28
Issue Date
2023-02-28

Please choose a citation manager

Content to export